Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.15.1 extracted from

  • Fedorov, V.N.; Salnikov, E.V.; Sidorov, A.V.; Bogatushin, A.V.; Fateev, M.M.
    Survival of rats with experimental chronic heart failure depending on pharmacodynamic and pharmacokinetic parameters of angiotensin-converting enzyme inhibitors and beta-adrenoceptor blockers (2006), Bull. Exp. Biol. Med., 141, 40-43.
    View publication on PubMed

Application

Application Comment Organism
medicine combination therapy with an angiotensin-converting enzyme inhibitor and beta-adrenoceptor blocker without intrinsic sympathomimetic activity should be used in the therapy of chronic heart failure Rattus norvegicus

Inhibitors

Inhibitors Comment Organism Structure
captopril lipophilic ACE inhibitors quinapril, enalapril, and captopril increase the survival and lifetime of rats with experimental chronic heart failure Rattus norvegicus
enalapril lipophilic ACE inhibitors quinapril, enalapril, and captopril increase the survival and lifetime of rats with experimental chronic heart failure Rattus norvegicus
quinapril lipophilic ACE inhibitors quinapril, enalapril, and captopril increase the survival and lifetime of rats with experimental chronic heart failure Rattus norvegicus

Organism

Organism UniProt Comment Textmining
Rattus norvegicus
-
with experimental chronic heart failure
-

Source Tissue

Source Tissue Comment Organism Textmining